1. Aali BS, Ghafoorian J, Mohamad-Alizadeh S. Severe preeclampsia and eclampsia in Kerman, Iran: complications and outcomes. Medical Science Monitor 2004;10(4):CR163-7. [
Google Scholar]
2. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. New England journal of medicine 2004 ;350(7):672-83. [
DOI:10.1056/NEJMoa031884] [
PMID]
3. F Gary C. Williams Obstetrics 24th Edition. Medical; 2014. [
Google Scholar]
4. Majidi S, Haki BK, Matlabi H. Factors Affecting Blood Pressure in Women with Hypertension Who Were Referred to Beyrag Health House-Tabriz 1391. Depiction of Health 2013;4(1):21-6. [
Google Scholar]
5. Zalak K, Kazemi Haki B, Matlabi H. Obstacles to Self-Care From The Viewpoint of TypeII Diabetic Patients and Guidelines to Remove Them. Jorjani Biomedicine Journal 2012; 10(1):30-7. [
Google Scholar]
6. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004;190(6):1520-6. [
DOI:10.1016/j.ajog.2003.12.057] [
PMID]
7. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70(12):2317-24. [
URL]
8. Belfort MA, Clark SL, Sibai B. Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate. Obstet Gynecol Surv 2006;61(10):655-65. [
DOI:10.1097/01.ogx.0000238670.29492.84] [
PMID]
9. Magee LA, Miremadi S, Li J, Cheng C, Ensom MH, Carleton B, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005;193(1):153-63. [
DOI:10.1016/j.ajog.2004.11.059] [
PMID]
10. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000;183(3):717-25. [
DOI:10.1067/mob.2000.106581] [
PMID]
11. Abbassi-Ghanavati M, Alexander JM, McIntire DD, Savani RC, Leveno KJ. Neonatal effects of magnesium sulfate given to the mother. Am J Perinatol 2012;29(10):795-9. [
DOI:10.1055/s-0032-1316440] [
PMID]
12. Zeng X, Xue Y, Tian Q, Sun R, An R. Effects and safety of magnesium sulfate on neuroprotection: A meta-analysis based on prisma guidelines. Medicine (Baltimore) 2016;95(1):e2451. [
DOI:10.1097/MD.0000000000002451] [
PMID] [
PMCID]
13. Sherwin CM, Balch A, Campbell SC, Fredrickson J, Clark EA, Varner M, et al. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic Clin Pharmacol Toxicol 2014;114(4):318-22. [
DOI:10.1111/bcpt.12166] [
PMID] [
PMCID]
14. Costantine MM, Weiner SJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU).). Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009;114(2 Pt 1):354-64. [
DOI:10.1097/AOG.0b013e3181ae98c2] [
PMID] [
PMCID]
15. Kamyar M, Manuck TA, Stoddard GJ, Varner MW, Clark E. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth. BJOG 2016;123(7):1161-6. [
DOI:10.1111/1471-0528.13460] [
PMID]
16. Mittendorf R, Dambrosia J, Pryde PG, Lee K-S, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;186(6):1111-8. [
DOI:10.1067/mob.2002.123544] [
PMID]
17. Stone SR, Pritchard JA. Effect of maternally administered magnesium sulfate on the neonate. Obstet Gynecol 1970;35(4):574-7. [
Google Scholar]
18. Ambadkar A, Prasad M, Chauhan AR. Neonatal effects of maternal magnesium sulphate in late preterm and term pregnancies. J Obstet Gynaecol India 2019;69(1):25-30. [
DOI:10.1007/s13224-017-1074-4] [
PMID] [
PMCID]
19. Greenberg MB, Penn AA, Thomas LJ, El-Sayed YY, Caughey AB, Lyell DJ. Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate. Am J Obstet Gynecol 2011;204(6): 515.e1-7. [
DOI:10.1016/j.ajog.2011.01.046] [
PMID]
20. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359(9): 895-905. [
DOI:10.1056/NEJMoa0801187] [
PMID] [
PMCID]
21. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol2009;113(6): 1327-33. [
DOI:10.1097/AOG.0b013e3181a60495] [
PMID]
22. Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol2009; 200(6): 595-609. [
DOI:10.1016/j.ajog.2009.04.005] [
PMID] [
PMCID]
23. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. Jama 2003; 290(20): 2669-76. [
DOI:10.1001/jama.290.20.2669] [
PMID]
24. Eftekhari J, Kazemi Haki B, Tizro P, Alizadeh V. A comparison to facilitate insertion of the laryngeal mask: term of recovery and postoperative nausea and vomiting after anesthesia with propofol-atracurium and thiopental-atracurium. Acta Med Iran 2015;53(2): 117-21. [
Google Scholar]
25. Sane S, Aghdashi MM, Kazemi Haki B, Gholamveisi B, Rajabzadeh M, Golabi P. The effect of pregabalin on the prevention of succinylcholine-induced fasciculation and myalgia. J Perianesth Nurs 2020;35(3): 255-9. [
DOI:10.1016/j.jopan.2019.11.005] [
PMID]